Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dirk G Dechering

Showing results (11-20 of 76) with videos related to

Pageof 8
Sort By:
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|August 3, 2015
Long-term follow-up of subcutaneous ICD systems in patients with hypertrophic cardiomyopathy: a single-center experienceGerrit Frommeyer, Dirk G Dechering, Sven Zumhagen, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|April 27, 2017
Catheter ablation for ventricular tachycardia in patients with cardiac sarcoidosis: a systematic reviewNikolaos Papageorgiou, Rui Providência, Konstantinos Bronis, et al.
International Journal of Cardiology|November 23, 2016
Experimental evidence for a severe proarrhythmic potential of levosimendanGerrit Frommeyer, Anja Kohnke, Christian Ellermann, et al.
International Journal of Cardiology|January 31, 2017
Acute infusion of levosimendan enhances atrial fibrillation in an experimental whole-heart modelGerrit Frommeyer, Anja Kohnke, Christian Ellermann, et al.
International Journal of Cardiology|June 14, 2017
Divergent antiarrhythmic effects of resveratrol and piceatannol in a whole-heart model of long QT syndromeChristian Ellermann, Julian Wolfes, Simon Kochhäuser, et al.
International Journal of Cardiology|November 19, 2016
Interactions of digitalis and class-III antiarrhythmic drugs: Amiodarone versus dronedaroneGerrit Frommeyer, Dirk Puckhaber, Christian Ellermann, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|August 7, 2017
The anti-influenza drug oseltamivir reduces atrial fibrillation in an experimental whole-heart modelGerrit Frommeyer, André Mittelstedt, Julian Wolfes, et al.
Journal of Cardiovascular Electrophysiology|January 10, 2018
Ryanodine-receptor inhibition by dantrolene effectively suppresses ventricular arrhythmias in an ex vivo model of long-QT syndromeGerrit Frommeyer, Julius Krawczyk, Christian Ellermann, et al.
Pharmacology|July 9, 2018
Ranolazine Prevents Levosimendan-Induced Atrial FibrillationChristian Ellermann, Anja Kohnke, Dirk G Dechering, et al.
Cardiovascular Toxicology|February 11, 2017
Severe Proarrhythmic Potential of the Antiemetic Agents Ondansetron and DomperidoneGerrit Frommeyer, Christina Fischer, Christian Ellermann, et al.
Pageof 8

Showing results (11-20 of 76) with videos related to

Sort By:
Pageof 8
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|August 3, 2015
Long-term follow-up of subcutaneous ICD systems in patients with hypertrophic cardiomyopathy: a single-center experienceGerrit Frommeyer, Dirk G Dechering, Sven Zumhagen, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|April 27, 2017
Catheter ablation for ventricular tachycardia in patients with cardiac sarcoidosis: a systematic reviewNikolaos Papageorgiou, Rui Providência, Konstantinos Bronis, et al.
International Journal of Cardiology|November 23, 2016
Experimental evidence for a severe proarrhythmic potential of levosimendanGerrit Frommeyer, Anja Kohnke, Christian Ellermann, et al.
International Journal of Cardiology|January 31, 2017
Acute infusion of levosimendan enhances atrial fibrillation in an experimental whole-heart modelGerrit Frommeyer, Anja Kohnke, Christian Ellermann, et al.
International Journal of Cardiology|June 14, 2017
Divergent antiarrhythmic effects of resveratrol and piceatannol in a whole-heart model of long QT syndromeChristian Ellermann, Julian Wolfes, Simon Kochhäuser, et al.
International Journal of Cardiology|November 19, 2016
Interactions of digitalis and class-III antiarrhythmic drugs: Amiodarone versus dronedaroneGerrit Frommeyer, Dirk Puckhaber, Christian Ellermann, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|August 7, 2017
The anti-influenza drug oseltamivir reduces atrial fibrillation in an experimental whole-heart modelGerrit Frommeyer, André Mittelstedt, Julian Wolfes, et al.
Journal of Cardiovascular Electrophysiology|January 10, 2018
Ryanodine-receptor inhibition by dantrolene effectively suppresses ventricular arrhythmias in an ex vivo model of long-QT syndromeGerrit Frommeyer, Julius Krawczyk, Christian Ellermann, et al.
Pharmacology|July 9, 2018
Ranolazine Prevents Levosimendan-Induced Atrial FibrillationChristian Ellermann, Anja Kohnke, Dirk G Dechering, et al.
Cardiovascular Toxicology|February 11, 2017
Severe Proarrhythmic Potential of the Antiemetic Agents Ondansetron and DomperidoneGerrit Frommeyer, Christina Fischer, Christian Ellermann, et al.
Pageof 8